|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Update on nonstefiodal anti-inflammtory drugs显示文摘 | Ardoin SP Sundy JS | 2006 | Curr opin Rheumatol2006，18，3： | 1 |
| 2 | 显示文摘 | Sempowski GD Hale LP Sundy JS | 2000 | J Immunol2000，164，： | 1 |
| 3 | Pharmacolinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout显示文摘 | Sundy JS Ganson N J Kelly S J | 2007 | Arthr Rheum2007，56，： | 1 |
| 4 | Leukemia inhibitory factor, oncostatin M, IL - 6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy 显示文摘 | Sempowski GD Hale LP Sundy JS | 2000 | J Immunol2000，164，4： | 1 |
| 5 | Update on nonsteriodal anti-inflammatory drugs显示文摘 | Ardoin SP Sundy JS | 2006 | Curr Opin Rheumatol2006，18，3： | 1 |
| 6 | Update on nonsteriodal anti-inflammatory drugs显示文摘 | Ardoin SP Sundy JS | | 0，，03： | 1 |
| 7 | Pharmacokineticsand pharmacodynamics of intravenous PEGylated recombinantmammalian urate oxidase in patients with refractory gout显示文摘 | SUNDY JS GANSON NJ KELLY SJ | 2007 | Ar-thritis Rheum2007，56，3： | 1 |
| 8 | Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout显示文摘 | Sundy JS Ganson NJ Kelly SJ | 2007 | Arthritis Rheum2007，56，： | 1 |
| 9 | Reduction ofplasma urate levels following treatment with multiple doses of pe-gloticase(polyethylene glycol-conjugated uricase)in patientswith treatment-failure gout:results of a phase II randomized study显示文摘 | SUNDY JS BECKER MA BARAF HS | 2008 | Arthritis Rheum2008，58，9： | 1 |
| 10 | Efficacy andsafety of intravenous(IV)pegloticase(PGL)in subjects withtreatment failure gout(TFG):Phase 3 results from GOUT1 andGOUT2显示文摘 | SUNDY JS BARAF HS BECKER MA | 2008 | Arthritis Rheum2008，58，9： | 1 |
| 11 | Chro-nic use of pegloticase:safety and efficacy update显示文摘 | SUNDY JS BARAF HS GUTIERREZ-URENA SR | 2009 | ArthritisRheum2009，60，10： | 1 |
| 12 | The combination of tranilast with allopurinol results in enhanced urate-lowering 显示文摘 | Sundy JS Kitt M Griffith SG | 2010 | Arthritis Rheum2010，62，10： | 1 |
| 13 | The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis:results of a placeho-controlled,monosequenee crossover,nonrandomised,single-blind pilot study显示文摘 | Terkeltaub R Sundy JS Schumacher HR | | 0，，： | 1 |
| 14 | The interleukin 1 in-hibitor rilonacept in treatment of chronic gouty arthritis:results of aplacebo-controlled,monosequence crossover,non-randomised,single-blind pilot study显示文摘 | Terkeltaub R Sundy JS Schumacher HR | 2009 | Ann Rheum Dis2009，68，10： | 1 |
| 15 | Rilonacept(interleukin-1 trap) in the prevention of acute gout flaresduring initiation of urate-lowering therapy: results of a phaseIIrandomized, double-blind, placebo-controlled trial 显示文摘 | Schumacher HR Jr Sundy JS Terkeltaub R | 2012 | Arthritis Rheum2012，64，3： | 1 |
| 16 | Pharmacokinetics and phar- macodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout 显示文摘 | Sundy JS Ganson N J Kelly S J | 2007 | Arthritis Rheum2007，56，3： | 1 |
| 17 | Rilonacept for goutflare prevention in patients receiving uric acid-lowering therapy:results of RESURGE, a phase IQ,international safety study显示文摘 | Sundy JS Schumacher HR Kivitz A | 2014 | JRheumatol2014，41，8： | 1 |
| 18 | Update on nonsteriodal anti-inflamma- tory dr/:gs显示文摘 | Ardoin SP Sundy JS | 2006 | Curr opin Rheumatol2006，18，3： | 1 |
| 19 | Update on nonsteroidal anti-inflammatory drugs 显示文摘 | Ardoin SP Sundy JS | 2006 | Curr Opin Rheumatol2006，18，3： | 1 |
| 20 | Update on nonsteriodal anti-inflammatory drugs显示文摘 | Ardoin SP Sundy JS | 2006 | Curr Opin Rheumatol2006，18，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员